Moxifloxacin-Optic, eye drops 0.5% 5 ml

Bacterial conjunctivitis caused by microorganisms sensitive to moxifloxacin.

Indications

Bacterial conjunctivitis caused by microorganisms sensitive to moxifloxacin.

Pharmacological effect

Pharmacodynamics.

Special instructions

For ophthalmic use only. Not for injection. It is not allowed to administer the drug subconjunctivally or directly into the anterior chamber of the eye.

Active ingredient

Moxifloxacin

Composition

Active ingredient:

Moxifloxacin hydrochloride

in terms of moxifloxacin

-5.45 mg

– 5.00 mg

Excipients:

sodium chloride

– 6.4 mg

boric acid

– 3.0 mg

hydrochloric acid solution 1 M or sodium hydroxide solution 1 M

up to pH 6.3 – 7.3

purified water

up to 1.0 ml

Contraindications

Hypersensitivity to any of the components of the drug or to other quinolones, children under 1 year of age.

Side Effects

The following adverse reactions are classified according to the following gradation of frequency of occurrence:
very common (≥ 1/10), common (≥ 1/100 to <1/10), uncommon (≥ 1/1,000 to <1/100), rare (≥ 1/10,000 to <1/1,000), very rare (<1/10,000). In each frequency group, adverse reactions are presented in descending order of severity.

Interaction

The interaction of topically administered moxifloxacin with other drugs has not been studied. Due to the low systemic concentration after topical application in the form of instillations, interaction with other drugs is unlikely.

Overdose

Due to the small capacity of the conjunctival cavity, the possibility of developing a local overdose when using drugs in the form of instillations is practically absent.

Storage conditions

Store at a temperature not exceeding 25 °C.

Shelf life

2 years.

Manufacturer

Lecco CJSC, Russia